Key clinical point: Three-dimensional (3D) laparoscopic myomectomy for uterine fibroids has no additional surgical benefit compared with conventional two-dimensional (2D) laparoscopic myomectomy.
Major finding: There were no significant differences between the 3D and 2D groups in terms of operative blood loss ( P = .421), change in serum hemoglobin levels ( P = .553), and operative time ( P = .344).
Study details: In a randomized controlled trial, 64 patients with symptomatic uterine fibroids were assigned either to 3D (n=32) or 2D (n=32) laparoscopic myomectomy.
Disclosures: No information on funding was available. The authors declared no conflict of interests.
Source: Song T and Kang DY. Eur J Obstet Gynecol Reprod Biol. 2021 Jul 23. doi: 10.1016/j.ejogrb.2021.07.036 .